The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma

Table 3

Univariate and Multivariate analyses of prognostic parameters for progression-free survival of patients with HCC.

Characteristics	Total (N)	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	Value	Hazard ratio (95% CI)	Value
Gender	373
Female	121	References
Male	252	0.982 (0.721–1.338)	0.909
Age	373
≤60	177	References
>60	196	0.960 (0.718–1.284)	0.783
Histologic grade	368
G1&G2	233	References
G3&G4	135	1.152 (0.853–1.557)	0.355
Pathologic stage	349
Stage I&Stage II	259	References
Stage III&Stage IV	90	2.201 (1.591–3.046)	<0.001	2.252 (1.625–3.122)	<0.001
DDX11-AS1	373
High	186	References
Low	187	0.642 (0.479–0.860)	0.003	0.615 (0.452–0.837)	0.002